Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Update on board meeting

October 27, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: LALPATHLAB Scrip Code: 539524 Sub: Consideration of 2nd Interim Dividend, if any for the Financial Year 2026-27 Ref: Intimation of Board Meeting dated September 25, 2026 Dear Sir/ Madam, This is in continuation of our earlier intimation dated September 25, 2026, with respect to Intimation of Board Meeting scheduled to be held on Wednesday, November 04, 2026, to inter-alia consider and approve the un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Half Year ended on September 30, 2026. We would like to further inform you that the Board of Directors at the same meeting scheduled for November 04, 2026, shall also consider 2nd Interim Dividend, if any, on the Equity Shares of the Company for the Financial Year 2026-27. We request you to kindly take the same on record. Thanking You, Yours Faithfully, For Dr. Lal PathLabs Limited Vinay Gujral Company Secretary & Compliance Officer